CAREHUB
BOARD BRIEFING · 22 NOVEMBER 2026

Digital pharmacies in Egypt

Market research and launch plan for pharmacy coordination and follow-up after home care

Executive decision

Decision requested from the board

Approve validation and setup for a controlled pilot. Start inside the CAREHUB app and through a secure web link in selected delivery zones in Nasr City and Heliopolis. Prioritize families after a home-care visit or discharge and people managing a parent’s medication. Before enabling prescriptions, approve the division of responsibilities, privacy arrangements and payment flow with licensed pharmacies.

Working proposition: “Your medication after the visit.” A licensed pharmacy reviews, dispenses and invoices. The platform coordinates basket, price and delivery confirmation and helps families reorder. CAREHUB adds clinical follow-up and home services, including at-home vaccination for eligible patients, subject to availability. Lead with reliable fulfillment and continuity of care, with delivery promises backed by operating data.

Decision Proposed position
Brand CAREHUB Pharmacy is the branded candidate, subject to a name and licensing review and customer testing. FAMILY PHARMA by CAREHUB is the launch alternative if reputation exposure, partner neutrality or clarity about the dispensing pharmacy carries more weight.
Expansion Cairo first, Giza after validating order density, and Alexandria in 2028 with a local partner if Cairo meets the expansion criteria.

Method. Desk research through 22 November 2026. Market series differ by date and definition. Company disclosures describe advertised features or historical measures. Comparative scores are based on desk research. Chain awareness, address-level coverage and actual fulfillment require the proposed fieldwork.

Market size and geographic priorities

Market indicators

Indicator Measure Relevance
Egypt's pharmaceutical market EGP 422 billion in 2025, about USD 8.5 billion, up 37% in value from 2024 and ranked 26th globally according to the EDA The figure spans channels beyond online pharmacies. Value growth may reflect repricing. [1]
Licensed pharmacies, Egypt 87,608 at the end of Q3 2026, according to published EDA figures Supply is fragmented. About 370,000 pharmacists is a separate September 2026 syndicate estimate, and its description of saturation concerns the labor market. [2]
General pharmacies, CAPMAS 79,115 in 2023 and a published national total of 86,741 in 2024. Comparable 2023 counts were 8,392 in Cairo, 7,482 in Giza and 5,271 in Alexandria Cairo and Giza totaled 15,874 in 2023. The published 2024 breakdown differs substantially, so 2023 is the local benchmark. General pharmacies and license counts have different definitions. [3]
Governorate population Cairo 10.4m, Giza 9.7m and Alexandria 5.6m, April 2025 published estimates Administrative boundaries are wider than delivery zones. Cairo and Giza together had about 20.1m residents. [4]
Recurring need 13.2m adults aged 20–79 with diabetes in 2024. Published CAPMAS figures estimate 10.2m older adults in 2026. A long-range projection puts the 60+ group at 8.4m in 2020 and about 22m in 2050 National signals of recurring demand. Actual demand depends on eligible households and prescriptions. [5]
Digital reach DataReportal estimates 99m internet users (82.2%) and 57.5m social media user identities for late 2026 A social identity may not represent a unique person. Assisted ordering remains important for some older adults. [6]
Annual inflation Nationwide 12% in October 2026 versus 12.8% in September. Urban 12.7% versus 13.9% Prices were rising more slowly, while delivery fees remain a concern for customers. [7]
Online pharmacy market estimate An earlier commercial estimate put it at USD 914m in 2022 and projected USD 1.86bn in 2027 A directional, low-confidence benchmark. Excluded from project market share. [8]

Chains and fulfillment channels

Name Footprint and channel Competitive or partner implication
El Ezaby Founded in 1975. 474 branches nationally at FY2025 close and EGP 14.23bn in revenue. Its current page lists 512 without an as-of date and older coverage estimated 350–400+. Cairo and Alexandria presence, app, web, 19600 and drive-through. The investor disclosure reports an economic interest of about 14% for B Investments. Strong inventory and direct-ordering benchmark. The circulated 49% figure differs from the disclosed economic interest and is excluded as a direct ownership figure. [9]
19011 Launched in 2017. Historical coverage cites 300+ outlets and a Roshdy-related acquisition. The operating entity entered bankruptcy in 2022, with reported resumption in 2024 and directory listings in Cairo and Giza. Measure brand recall and verify the current entity and active outlets before contracting. The historic count is excluded as a current footprint. [10]
Seif Industry coverage dates it to 1980 and cites 80+ branches, a figure to update. Official locator and app. Directories list 19199 and WhatsApp. Verify both for current orders. Branch examples include New Cairo, Abbassia, Shubra, Mohandessin and Alexandria's Ibrahimia. Benchmark beauty and personal care assortment and app-to-branch service. [11]
Roshdy Industry sources cite a 2008 start. Directory presence includes New Cairo, Kafr Abdo and Alexandria. A historical transaction reportedly involved about 95 outlets during 19011's expansion. Verify current corporate affiliation and active branches. [10][12]
Misr Pharmacies An industry directory dates the chain to the early 2000s. Cairo and Giza presence. The shop and app advertise delivery in Greater Cairo and Alexandria. Mixed-basket reference. Validate suburban coverage and handling of a missing item. [9][12]
Abdin and Care Abdin's official locator includes Heliopolis and Giza, with a web shop. Care is a comparison candidate. Sector coverage describes a 2003 start and a large footprint, pending entity and branch verification. Include them in local mapping without assuming inventory or commercial terms. [9][12]
Khalil, Alexandria 19040 and listings in Raml Station, Moharam Bek, Mostafa Kamel, San Stefano and Agami. Similar names are used elsewhere. Potential local partner after entity and branch checks. [13]
El Shazly, Nour and El Tarshouby El Shazly is listed in Miami with delivery, Nour appears in regional network directories, and El Tarshouby has a local listing. App availability, active branch counts and fulfillment speed need validation. Compare alongside El Ezaby, Seif, Roshdy, Misr and independents at the same addresses. [13]

District sequence. Small zones in Nasr City and Heliopolis first. Add the Fifth Settlement after validating drive times. Maadi is an alternative if referrals are stronger. Dokki, Mohandessin, Sheikh Zayed and 6th of October are separate Giza clusters. In Alexandria start field validation in Smouha and Sidi Gaber and check Ibrahimia and local-chain catchments. Prioritize independents and midsize chains (2–10 outlets) for workable service agreements. Negotiate with larger chains where they improve coverage and preserve the ability to manage the customer relationship. Prioritize Greater Cairo in fieldwork and assess Alexandria for a later phase.

Serviceable demand

Layer Estimate and calculation
Geographic TAM 229,830 households in East Nasr City (173,455), West Nasr City (19,719) and Heliopolis (36,656), July 2025 estimates. [4]
Pilot SAM About 10,055 households = 229,830 × 35% inside the launch zones × 25% with recurring need × 50% channel fit and eligibility. The multipliers are assumptions.
Observed SOM Measure after the pilot as purchasing households that complete an order relative to eligible households in the service area. Recalculate SAM for each district as coverage expands.

Three-week fieldwork. 180 survey responses (120 Greater Cairo and 60 Alexandria), 24 family interviews (18/6), 12 pharmacy interviews (9/3, within a 10–15 partner discussion range), and 48 service checks (36/12). Recruit post-discharge families, caregivers and Chefaa, Yodawy, Vezeeta, El Ezaby and neighborhood pharmacy customers. Measure top of mind, unaided and aided awareness, last purchase, acceptable price, trust and perceived care depth. Use consistent addresses, times and baskets, permitted real orders and authorized prescription scenarios. Track basket completeness, confirmation and delivery time, fees, stockout handling, invoices and refunds. Use the sample directionally.

Chefaa, competitors and positioning

How Chefaa works

Layer Published offer or evidence
History and scale Founded in 2017 and operational from 2018 according to historical coverage. Chefaa reports 1,000+ partner pharmacies. Other disclosures cite 20+ governorates and 41,000–50,000 products, with separate listings citing 1,500+ pharmacies and 1.5m monthly users. Definitions and dates differ. The Google Play snapshot showed 1M+ downloads, 4.2 stars and about 17.5k reviews. Downloads span more than one market. [14]
Core journey Users enter a location and search by name or upload a prescription or product photo. The platform coordinates with a partner pharmacy that sells, dispenses and invoices under the published model. Features include advertised 24/7 pharmacist support, scheduling, tracking, online payment and cash on delivery. [14]
On-demand orders Published times vary, including 30 or 90 minutes in different sources or routes. Actual time depends on address, stock and order type. Chefaa offers an alternative route if a nearby pharmacy is unavailable. [14][15]
Super Saving The monthly prescription page advertises up to 15% on local and 5% on imported medicines, with a minimum EGP 700 order and delivery in 1–3 days. Route and product terms apply. [15]
Chefaa Plus Published at EGP 60 per month, from EGP 80, with a stated EGP 300 pharmacy order minimum and other benefits including consultations and labs. Services vary by route and partner. [15]
Revenue and expansion Historical comments describe commissions and subscriptions. Extensions include pharmacy benefits management, partner supply through Supply/Makazen and Bi-Hub. A USAID-backed digitization initiative targeted 250 pharmacies when announced. The December 2023 USD 5.25m round was co-led by Newtown Partners and Global Brain, with eight Saudi cities disclosed at that time. A later round could not be confirmed. [16]

Market positioning. Chefaa combines convenience, savings and recurring medication orders. Local partner execution can introduce variability, which should be measured. Savings and convenience are prominent in the shop, with public evidence of chronic-care features, PBM and membership-related services.

Direct and adjacent competitors

Competitor Offer Implication
Yodawy On-demand prescriptions, chronic refills, digital approvals, eRX and pharmacy benefits management (PBM). The company lists 3,000 pharmacies and 38 cities. Investment-era coverage cited 35 health and insurance organizations whose networks reached 800+ companies. Dealroom reports 6m+ lifetime prescriptions, 200,000+ patients per month and USD 34.5m in total funding. Ezdehar's USD 10m investment was announced in January 2024. Metrics differ in period and scope. [17] Closest comparable to Chefaa. Benchmark insurance, approvals and recurring fulfillment before institutional expansion.
Vezeeta Pharmacy Medication ordering alongside appointments, prescriptions, home visits and labs. Pharmacy service reported from August 2020. Shamel advertises up to 80% savings on eligible services. EVA Pharma partnership covers diabetes and obesity. [18] Closest benchmark for integrating orders into a broader care journey. Test caregiver access and follow-up.
Doxx Pharmacy page within a healthcare platform using a partner network. [18] Additional benchmark for an integrated care platform.
Talabat and Breadfast Talabat lists pharmacies by address. Breadfast adds pharmacy and personal care to a daily basket and advertises coverage in Cairo, Giza and Alexandria. [19] Pressures convenience, speed and fees. Verify prescription acceptance and product availability by address.
Amazon Now Egypt launch in July 2026 for groceries and essentials in selected areas of Cairo, Giza, Alexandria and the North Coast. [19] Speed benchmark for daily commerce. Include it in prescription comparisons only with supporting evidence.
Chains and independents Chain apps connect inventory, physical outlets and established brands. El Ezaby advertises prescription management in its app. Neighborhood pharmacies build loyalty through direct contact. [9][11][12] Alternatives for urgent and recurring orders and possible fulfillment partners under the right service agreements.

Competitive profile matrix CPM

Factor Weight Chefaa Yodawy Vezeeta El Ezaby Breadfast CAREHUB proposed model
Pharmacy coverage 15% 4 4 3 3 2 2
Delivery speed 12% 3 3 3 3 4 3
Brand trust 12% 3 3 4 4 3 3
Chronic and refill program 12% 4 4 2 2 1 4
Payer integration 10% 2 4 2 2 1 2
Medical integration depth 10% 2 2 4 2 1 4
Assortment 8% 4 3 3 3 2 3
Price and value 7% 4 3 3 3 3 3
App experience 5% 3 3 4 3 4 4
Financial capacity 5% 3 4 4 4 3 2
Regulatory compliance 4% 3 3 2 4 3 4
Weighted score 100% 3.22 3.32 3.06 2.89 2.30 3.01

Desk assessment on a 1–4 scale. CAREHUB scores are assumptions for the proposed model. The compliance rating is a research judgment. Yodawy leads on payer integration. CAREHUB combines clinical care and chronic refills, with a coverage gap. Re-score after testing fill rate, timing, invoices, refunds, caregiver access and reordering.

Directional perceptual map. The horizontal axis measures delivery speed and convenience. The vertical axis measures depth of care. Vezeeta sits closer to integrated care and Yodawy is strong in insurance and chronic medication. Chefaa scores strongly on ordering convenience and refills. Chains cluster around fulfillment, quick commerce toward speed and neighborhood pharmacies near direct service. The proposed CAREHUB offer combines deeper follow-up with delivery times that operations can confirm. Validate the positions with customers.

Depth of care ↑
Neighborhood pharmacy
Vezeeta
Yodawy
Chefaa
El Ezaby and chains
Breadfast / Talabat
CAREHUB proposed model
Delivery speed and convenience →

Strategic assessment and brand

PESTEL | External factors

Factor Operational implication Impact and horizon
Political and institutional Minya started a pilot in the second phase of universal health insurance. The published implementation group includes Minya, Kafr El Sheikh, North Sinai, Damietta and Matrouh. Cairo and Alexandria are outside that implementation list. Discussion about Alexandria does not establish active coverage. Contracting can route some demand through institutional channels. [20] Medium, long term, opportunity and threat
Economic Easing inflation offers some stability while customers remain price sensitive. Market value growth supports the opportunity. Decree 480/2026 sets drug pricing and review rules. Its six-month provisions apply to specified calculations and conditions. They do not imply automatic repricing of every medicine. Calculate cost and shortage exposure by basket. [1][7][20] High, short and medium term, opportunity and threat
Social Aging and chronic illness support follow-up demand. Counterfeit concerns and trust make source verification important. Older adults may need human assistance. [5][21] High, medium and long term, opportunity and threat
Technological Internet adoption and digital licensing improve access. National traceability under Decree 475/2025 provides a basis for verification as phased implementation proceeds. [2][6][20] High for access and medium for traceability, opportunity
Environmental Limited near-term impact. Define expiry and return handling, secure packaging and cold-chain waste handling once introduced. Limited, near term
Legal Historical syndicate objections covered online sale and pricing, with Yodawy and Vezeeta named in coverage and risks including supplier objections, ad intervention or complaints. Historical coverage also reported an objection to a distributor working with a platform. Authorities reported closing 234 pages for unlawful promotion in H1 2026. Assess the service, advertising and data flow on their merits. [21][22][23] Critical, short term, threat

Five Forces and entry barriers

Force Assessment Decision implication
Existing rivalry Very high Platforms and chains offer overlapping services. Regulated prices increase the importance of fees, coverage and reliable fulfillment.
New entrants High for basic ordering, medium for reliable care coordination A simple platform and partner inventory lower upfront costs, while large entrants bring existing customers. Compliance, operating capability and basket availability take longer to establish.
Substitutes High Walk-in branches, telephone, WhatsApp where available and insurance channels. Test actual delivery fees by address.
Buyer power High Customers can switch easily and insurers negotiate on volume. Earn retention through good follow-up and easy reordering, preserving choice and data rights.
Supplier power Low across a fragmented market, medium to high in some zones Stockouts, operating hours, refrigeration and distributor dependency can reduce alternatives. Maintain a qualified primary and backup pharmacy per zone and monitor concentration.
Complementors Clinicians, labs, payers and payment providers Connect care, orders and follow-up, then institutional settlement.
Barrier Severity Required response
Licensing, objections, advertising and privacy Critical Written advice, defined dispensing and payment flow, and approved advertising and prescription handling before launch.
Trust and source verification High Identify the pharmacy, provide pharmacist review, enable verification where applicable and support customers through 15848.
Partner density and inventory High in execution Primary and backup partners by zone, an initial assortment based on demand analysis, and monitoring of complete baskets.
Delivery and cold chain Medium to high by category Compare two carriers and test scheduled delivery. Validate the cold chain before adding products that require it.
Unit economics and acquisition High Measure per-order economics and repeat behavior. Test a service fee, an institutional contract or a viable membership alongside the basket.
Capital and technology Medium MVP inside the app and via web, then inventory automation after validation. Funded peers can scale more rapidly, so keep the launch geography tight.
Insurance integration and brand awareness in a new category High for integration and medium for awareness Start with direct payment, then test a payer. Measure whether home-hospital trust transfers to pharmacy support.

SWOT for Chefaa and CAREHUB

Dimension Chefaa CAREHUB initiative
Strengths Early entry, network and assortment, on-demand and savings routes, chronic refill and pharmacist access, B2B supply, external funding and Saudi presence. Multidisciplinary home-hospital service, case management, field teams and 15848. CAREHUB has 10,000 customers, based on the internal figure provided. Existing visit and discharge referrals provide a starting audience for the pilot.
Weaknesses Partner-dependent execution, inconsistent disclosed figures, minimum order and coverage constraints. Savings may attract price-sensitive users. The Egyptian consumer offer makes insurance and integrated clinical care less prominent than at Yodawy and Vezeeta, while PBM and Plus are documented. Pharmacy network, licensing arrangement and dedicated product and commerce capability need validation or development. Relative funding needs review, and the brand is associated with acute care.
Opportunities Chronic demand, aging, internet adoption and traceability. Fragmented independent supply, payer and procurement opportunities, and easing inflation. Post-discharge care, a selected partner network, and home-care service integration. Expand to external clinics and institutional contracts as performance allows.
Threats Enforcement, advertising restrictions, chain apps, quick commerce and Yodawy's payer strength. Repricing and shortages vary by SKU. A historical trade estimate put shortages below 5%, while local checks should drive operations. [20][21] Industry pressure plus spillover from a dispensing or data incident to the home-hospital brand, and changing supply or CAC.

TOWS in practice. SO uses home care and referrals to activate post-discharge medication support. ST makes pharmacist review, licensing, traceability and compliance part of trust. WO assigns a Partnerships Manager to build the selective network and a Product Lead to deliver the MVP and train support. WT limits geographic rollout and protects contribution and reputation before spending grows.

Operating model and brand choice

Growth strategy. Product development with existing CAREHUB families, followed by market development with families and clinics in Greater Cairo and Alexandria. Competitive strategy. Focused differentiation through medication follow-up as part of the home-care journey.

Weighted operating model assessment Focused service via partners General marketplace Owned chain
Fit with CAREHUB referrals · 25% 5 2 4
Control of experience · 20% 4 2 5
Speed to validate and capital · 20% 5 4 1
Early zone contribution · 20% 4 2 2
Chronic and institutional scalability · 15% 4 3 4
Score /5 4.45 2.55 3.20
Weighted brand assessment CAREHUB Pharmacy FAMILY PHARMA by CAREHUB Standalone FAMILY PHARMA
First-order trust · 25% 5 4 2
Acquisition efficiency · 20% 5 4 2
Containment of fulfillment risk · 20% 1 3 5
Partner neutrality · 15% 2 4 5
Positioning fit · 10% 5 5 3
Group architecture · 10% 2 4 5
Score /5 3.45 3.90 3.45

Brand decision rule. CAREHUB Pharmacy is the candidate for testing trust transfer and referrals. The endorsed option leads the desk assessment on partner fit and reputational containment. Test all three names on matched pages and size the sample before launch. Measure completed-order conversion and correct identification of the seller. Test standalone FAMILY PHARMA under VALUECREST after three months of stable performance and evidence of external acquisition. “Maw‘ed Dawa” and “Dawa El-Eila” are research candidates. Descriptive names such as “Mozmen,” “El-Rosheta” and “Dawa’i” require clearance. Check trademark classes, domains and app-store names. Test CAREHUB Pharmacy and its Arabic equivalent only after reviewing what the name implies about licensing.

Marketing and rollout

Segments and positioning

Priority Customer Need and route to market
Primary · Family caregiver Son or daughter aged 30–50, often working and making or paying for decisions. A/B/C1 is a hypothesis. Nasr City and Heliopolis first, then New Cairo, Maadi and Zayed. Manage prescriptions for more than one person and confirm costs from a different address. Use care referrals, content, clinics and residential communities.
Primary · After care Families of older or chronically ill patients after an eligible discharge or visit, sometimes with long or changing prescriptions. Case coordinator introduces optional first ordering and later reminders. Visits, home sampling and nursing are available through separate eligible care pathways.
Secondary · Independent chronic patient Age 50–65 as a hypothesis, with diabetes, hypertension or heart disease and existing local shopping habits. Stock availability and a clear way to deal with missing items. Reach through clinics, search and phone support.
Selective · OTC and supplies Day-to-day demand in serviceable zones. Clear fees and mixed baskets. Mother and child products and families aged 25–40 are deferred as a primary audience due to quick-commerce pressure.
Institutional · Clinics, employers and payers Organizations that need structured referrals or approvals and reconciliation. Clinic referrals from launch. Test one employer or TPA contract near the end of year one if ready. Scale institutional channels in year two.

Positioning. For Cairo families managing medication for an older or chronically ill person, CAREHUB coordinates orders and follow-up with licensed pharmacies and connects families to home care when appropriate. Test expected order value and repeat behavior through recency, frequency and monetary analysis (RFM). Test the lines “Their medication on time, with peace of mind” and “Medication delivered, follow-up continues.” Support the offer with pharmacy invoices, confirmation, pharmacist review, authorized caregiver access and demonstrated availability of home services.

Selling points

Selling point Value for the family
At-home vaccination A qualified CAREHUB clinical team administers available vaccines in a home visit. The team checks suitability for the patient’s age and condition and follows the vaccine’s transport and storage requirements. [24]
Medication follow-up after a visit or discharge A licensed pharmacy reviews the prescription. The family sees confirmed items, cost and the delivery window. An authorized caregiver can follow the order and review when to reorder.
Home care when needed Families can arrange clinical follow-up, home sampling or nursing within the care journey according to need and eligibility.

7Ps | Offer and customer experience

Element Execution
Product MVP for secure prescription upload, coverage, confirmation, tracking, payment and authorized family access. Offer reminders based on the approved medication plan and a configurable review around day 25. A qualified pharmacist reviews interactions within the agreed scope. Clinical follow-up, lab sampling, visits and nurse-administered injections use the relevant home-care pathway and eligibility criteria.
Price The pharmacy applies the regulated medicine price where applicable, with a separately disclosed service fee. Test EGP 29/39/49. Launch economics exclude medicine discounting. Test bundles for eligible non-drug items. Use Van Westendorp and a purchase test for CAREHUB Care Plan at EGP 99 a month. The original proposition includes unlimited free delivery, pharmacist consultation, a monthly clinician call and nursing priority. Compare it with a capped or scheduled option and cost actual usage before committing.
Place Module in the current app, secure web link and assisted entry through 15848. Use approved WhatsApp support for navigation without sending prescriptions through the general channel. Selective distribution with a qualified primary and backup partner as the network grows.
Promotion Pull and corporate profile. Start with post-care referrals, clinician and pharmacist reels, SEO and ASO. Meta, TikTok and Google require sponsor and destination eligibility. Test caregiver communities, clinics, clubs and compounds. Test an “invite a family” Care Plan month after validating economics. The PR story is the link between a digital pharmacy service and a home hospital. A market-first claim requires evidence and review.
People Licensed pharmacists and clinical reviewers as applicable, case coordinators, Product Lead, Partnerships Manager, growth, operations, finance and privacy. Train carriers in older-adult communication and cold-chain handling before introducing the latter.
Process Start from referral or search, secure review and confirmation, then delivery and invoice. The operations section sets the measurement and escalation steps.
Physical evidence Tamper-evident packaging in approved Sea Blue and Amber Gold, pharmacy invoice, reviewer identity where appropriate, order ID and proof of delivery. Enable official verification where supported and use validated cold packaging later. Provide a large-print medication schedule from the reviewed plan and readable app controls.

Funnel, channels and content

Stage Marketing activity Measure
Awareness TOFU “Do you manage your family's medication?” reel and education on organizing family medicines and common diabetes medication-management mistakes, with no product names. Local search pages, clinics and community clubs. Serviceable visits and brand recall.
Consideration MOFU Explain the dispensing pharmacy, fees, coverage and privacy. “A call between two homes” demonstrates authorized family status tracking. Provide an FAQ and short demo. Eligible users starting the order journey.
First order BOFU In-app post-visit CTA and QR follow-up card. “The visit is over. Shall we arrange the medication?” video. Use permitted service promotion and local search terms such as “medicine delivery” or “24-hour pharmacy” only after channel and claim review. First completed order per household and channel CAC.
Repeat With consent, send service updates such as “Order 4821 is confirmed. View the pharmacy and delivery window via the secure link,” then follow up and remind about a new order. Second order within 60 days and month-three refill retention.
Referrals and partners Generic share link after successful delivery. Test a membership incentive conditionally. Approach internal medicine, cardiology and family medicine clinics. Activate referrals as partners become ready. Test relevant creators and older-adult communities. Attributed first buyers and referrals by clinic.

Pilot funnel measurement. Follow eligible families from first exposure through opt-in, order start, completion and reordering. If paid channels are ineligible, prioritize referrals, CRM, SEO and research. Track app activation and eligible visits alongside completed orders.

Rollout phases

Phase Deliverables Conditions to progress
Preparation · December 2026–February 2027 Review legal, privacy, payments, contracts and naming. Build the MVP, train the team and compare couriers. Approve the order pathway, qualify a network that covers the service area and test ordering, invoicing and refunds.
Controlled pilot · March–April 2027 Start with CAREHUB customers, test the discharge and follow-up protocol, and review shortages, delays and refunds. Review service quality and family satisfaction and resolve exceptions before expanding.
East Cairo · May–August 2027 Expand gradually and test pricing, branding, referrals and clinic channels. Evidence of reliable fulfillment, repeat demand and viable channel contribution.
Giza · September 2027–March 2028 Test selected areas in Mohandessin, Dokki, Zayed and 6th of October. Assess an employer or TPA contract. Validate order density, network quality and operating economics.
Alexandria · 2028 Pilot with a local chain and backup supply, and assess a standalone app. Confirm the local service area and the ability to replicate Cairo’s operating model.

The dates are an indicative sequence and will be reviewed as the service becomes ready.

Operations and governance

Order journey

  1. Referral and choice. The coordinator offers the service after an eligible visit or discharge. Families check coverage, choose a channel and authorize who can follow the order. Their usual pharmacy remains an option.
  2. Review. Send only necessary information through an approved channel to a licensed pharmacist. Record when review begins after the information is complete and when the order is confirmed. Inform the customer of the delivery window. The pharmacist checks the prescription and interactions within scope and confirms items and quantities.
  3. Confirmation. The partner discloses available and missing items, price, pharmacy invoice and delivery window. For shortages offer waiting, partial fulfillment or cancellation. Substitution follows applicable rules, patient approval and prescriber involvement where required. Retries must not duplicate payment or ordering.
  4. Delivery and settlement. The licensed pharmacy prepares the order. Use sealed packaging by category, proof of delivery and the seller's invoice. Limit courier access to delivery data. Reconcile card or cash, approved fees and refunds with the partner. Defer pharmacy platform delivery for products requiring refrigeration, specially controlled products and complex injectables until their pathway is validated. Injection nursing and vaccination are booked as clinical home visits through the appropriate care pathway.
  5. Follow-up. Call on day three where the protocol applies. Remind around day 25 or an appropriate date. The system may draft a reorder for customer confirmation and prescription validation before fulfillment. Pause scheduling when a treatment plan changes and escalate warning symptoms to the approved clinical pathway.
  6. Exceptions. Support logs shortages, delays, damage, payment failures and refunds. A serious dispensing or privacy incident pauses the affected pathway for escalation and root-cause review before restart.

Requirements before enabling prescriptions

Topic Required decision
Legal status Review Pharmacy Practice Law 127/1955, amendment 90/2025 and applicable rules. Define the intermediary role, permitted display and routing, seller and professional responsibilities, licensing and the partner option. Seek regulatory clarification as advised. [22]
Pricing and settlement Identify who sets and invoices the medicine price, who takes payment, platform fees and taxes, and how funds and refunds settle. Contractual income could be structured as a service or institutional fee within the approved scope.
Advertising and privacy Review EDA online materials guidance, the scope of Decree 579/2026 and platform rules. Under Law 151/2020 and Executive Regulations 816/2025, the DPO reviews controller and processor roles, consents and permissions or licenses, delegation, hosting and transfers, retention and deletion. Keep patient and prescription data out of ad tools, pixels, campaign links and social platforms. [22][23]
Partner quality Verify licensure, stock, invoice and incident handling. Agree confirmation, fill rate, on-time delivery, failure costs, rescheduling, future cold chain and refund ownership. Require second checks when the safety protocol calls for them.
At-home vaccination The clinical team confirms eligibility, availability and consent, manages the cold chain, and records the vaccination and approved follow-up guidance. [24]

RACI | Execution ownership

Activity Responsible Accountable Consulted Informed
Legal and data Legal and DPO CEO Pharmacy lead Board
Pharmacy contracts Partnerships Executive Partnerships Manager Operations and Finance CEO
App development Tech and QA Product Lead Care Coordination Marketing Manager
Brand and content Content Specialist Brand Manager Clinical reviewers CEO
Paid media Performance Specialist Performance Lead Brand and Legal Head of Growth
Discharge and activation Case Managers Care Coordination Lead Medical Director Head of Growth
Fulfillment and settlement Operations supervisors and Finance Operations Manager Partners and pharmacy lead GM and Growth

Principal risks

Risk Likelihood / impact Response
Complaint or enforcement Medium / critical Written review, controlled pricing and advertising, and clear division of pharmacy and platform duties.
Dispensing error or data incident Low / critical Verification, role-based access and contractual accountability, with pause and escalation protocols.
Competitor discounting or higher CAC High / medium Keep the follow-up proposition focused and stop channel expansion when cohorts cannot repay acquisition.
Partner service or stockout Medium / high Qualified backup, monthly scorecard, early notice and a pharmacist-led shortage pathway.
Brand confusion Medium / medium Link the service to continuity after discharge. Test correct seller identification and the impact of incidents on the home-hospital brand.

Revenue model and order economics

Revenue sources

Route What to test
Pharmacy order coordination A disclosed service fee or contractual service income from a qualified partner, subject to the approved structure and division of responsibilities.
CAREHUB Care Plan Test family willingness to pay for follow-up services. Cost benefits from actual usage and test scheduled delivery as part of the offer.
Employer and payer contracts Pilot a contract when integration and settlement are ready. Measure its effect on repeat demand and service quality.
Home care services Charge for delivered follow-up, nursing, labs and vaccination under the applicable service terms. Assess how benefits fit the care journey and account for each service once.

How to measure viability

  • Gross merchandise value (GMV) is the value of products sold through the service. CAREHUB’s legal role and contract determine the revenue it can recognize.
  • Contribution per order is the platform’s collected fees and approved contractual income after delivery, payments, support, incentives and fulfillment failure costs. Test the impact of zero basket-linked income before expanding.
  • Customer acquisition cost (CAC) is attributed channel spend divided by new customers who complete an order. For the chronic program use qualifying new subscribers. Payback is measured from actual order and membership contribution after servicing costs.
  • Break-even and settlement. Calculate break-even from fixed costs, acquisition costs and realized order contribution. Track collections, partner settlement dates and refunds to assess liquidity needs.

Performance and expansion criteria

Performance dashboard

Area Metrics and definitions Owner and frequency
Orders and funnel First-order households, completed orders net of full refunds, average basket, GMV and eligible household opt-in. Growth, CRM and Finance, weekly and monthly.
Post-discharge activation Eligible households activating within 30 days of discharge, with referral progress and drop-off tracked. Care Coordination, monthly.
Repeat use and membership Second order within 60 days, month-three refill retention by chronic-care cohort, and active Care Plan members if approved. Product and CRM, monthly.
Economics Contribution per order, channel CAC, and payback based on cohort contribution. Growth and Finance, weekly and monthly.
Delivery and partners Complete eligible original baskets, confirmation time, delivery within the original promise, cancellations after confirmation, and compliance with pharmacy service agreements. Operations, daily. Partner reviews monthly.
Safety and privacy Confirmed dispensing errors, data incidents, and cold-chain or vaccination documentation issues. Pause and review the affected pathway immediately after a serious incident. Pharmacy Lead, clinical team and DPO, continuously.
Satisfaction and awareness NPS after 30 days, post-order CSAT, app-store ratings, and aided and unaided awareness among families in the service area. Product and CX monthly, Brand quarterly for awareness.

Review and expansion. The project lead reviews operations and channels weekly, economics monthly and expansion decisions quarterly. Expansion depends on reliable basket fulfillment and delivery, repeat ordering in mature cohorts, and viable per-order and acquisition economics. If retention or contribution weakens, review the offer, contract and channel before expanding. Alexandria requires local validation and a backup partner.

Data required for approval

  • Unique eligible CAREHUB households by district, monthly discharges and visits, chronic-care share, contact opt-in and CRM referral capability. Review the internal customer-base data.
  • Pharmacy and payer interviews, fulfillment and courier costs, contractual fees, payment methods, settlement and refunds. Verify Alexandria branches by address.
  • Comparative order results, fee and membership research, and brand testing. Update the CPM, coverage and funnel using observed performance.
  • Written legal review of prescriptions, contracts, promotion and privacy, a backup agreement per area, and a documented vaccination pathway with the clinical team.

Evidence and limitations

Published offers and footprints can change by address and date. Comparable digital market shares by governorate, competitor profitability, actual fulfillment quality and active local branch counts need additional validation. This study did not run paid mystery orders or primary interviews. Market and regulatory evidence is linked to the sections that use it.

  1. Egyptian pharmaceutical market
  2. Pharmacy licensing and labor market
  3. General pharmacies
  4. Population and households
  5. Demand and aging
  6. Digital adoption
  7. Inflation
  8. Commercial e-pharmacy estimate
  9. El Ezaby
  10. 19011 and Roshdy
  11. Seif
  12. Roshdy, Misr, Abdin and Care directories
  13. Alexandria pharmacies
  14. Chefaa · journey and scale
  15. Chefaa · delivery and membership
  16. Chefaa · partners and funding
  17. Yodawy
  18. Vezeeta and Doxx
  19. Quick commerce
  20. Insurance, pricing and traceability
  21. Enforcement and market objections
  22. Pharmacy practice and advertising
  23. Data protection and channel policy
  24. Vaccination and cold chain